
Scott Long
Examiner (ID: 7374, Phone: (571)272-9048 , Office: P/1633 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633 |
| Total Applications | 882 |
| Issued Applications | 557 |
| Pending Applications | 29 |
| Abandoned Applications | 301 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 250722
[patent_doc_number] => 07582478
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-01
[patent_title] => 'Cleaved serum response factor in cardiac diagnosis and therapy'
[patent_app_type] => utility
[patent_app_number] => 10/763037
[patent_app_country] => US
[patent_app_date] => 2004-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 32403
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/582/07582478.pdf
[firstpage_image] =>[orig_patent_app_number] => 10763037
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/763037 | Cleaved serum response factor in cardiac diagnosis and therapy | Jan 21, 2004 | Issued |
Array
(
[id] => 4579861
[patent_doc_number] => 07850956
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-14
[patent_title] => 'Immunization by inoculation of DNA transcription unit'
[patent_app_type] => utility
[patent_app_number] => 10/763049
[patent_app_country] => US
[patent_app_date] => 2004-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 30
[patent_no_of_words] => 14954
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/850/07850956.pdf
[firstpage_image] =>[orig_patent_app_number] => 10763049
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/763049 | Immunization by inoculation of DNA transcription unit | Jan 21, 2004 | Issued |
Array
(
[id] => 6983232
[patent_doc_number] => 20050153302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Method for comprehensive identification of cell lineage specific genes'
[patent_app_type] => utility
[patent_app_number] => 10/759334
[patent_app_country] => US
[patent_app_date] => 2004-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8619
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153302.pdf
[firstpage_image] =>[orig_patent_app_number] => 10759334
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/759334 | Method for comprehensive identification of cell lineage specific genes | Jan 15, 2004 | Abandoned |
Array
(
[id] => 6971730
[patent_doc_number] => 20050037440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Methods of identifying longevity modulators and therapeutic methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/746910
[patent_app_country] => US
[patent_app_date] => 2003-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 20538
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20050037440.pdf
[firstpage_image] =>[orig_patent_app_number] => 10746910
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/746910 | Methods of identifying longevity modulators and therapeutic methods of use thereof | Dec 22, 2003 | Issued |
Array
(
[id] => 7275053
[patent_doc_number] => 20040234504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Methods of inhibiting gene expression by RNA interference'
[patent_app_type] => new
[patent_app_number] => 10/742740
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17458
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20040234504.pdf
[firstpage_image] =>[orig_patent_app_number] => 10742740
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/742740 | Methods of inhibiting gene expression by RNA interference | Dec 17, 2003 | Abandoned |
Array
(
[id] => 4498666
[patent_doc_number] => 07919236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-05
[patent_title] => 'G-proteins'
[patent_app_type] => utility
[patent_app_number] => 10/538038
[patent_app_country] => US
[patent_app_date] => 2003-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8810
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/919/07919236.pdf
[firstpage_image] =>[orig_patent_app_number] => 10538038
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/538038 | G-proteins | Dec 16, 2003 | Issued |
Array
(
[id] => 5661446
[patent_doc_number] => 20060252042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Methods of treatment of feeding disorders or disorders of glucose uptake and for modifying metabolism and identifying therapeutic reagents therefor'
[patent_app_type] => utility
[patent_app_number] => 10/539105
[patent_app_country] => US
[patent_app_date] => 2003-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 33150
[patent_no_of_claims] => 101
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252042.pdf
[firstpage_image] =>[orig_patent_app_number] => 10539105
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/539105 | Methods of treatment of feeding disorders or disorders of glucose uptake and for modifying metabolism and identifying therapeutic reagents therefor | Dec 15, 2003 | Abandoned |
Array
(
[id] => 5674142
[patent_doc_number] => 20060179497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Methods to treat conditions associated with insulin signaling dysregulation'
[patent_app_type] => utility
[patent_app_number] => 10/537848
[patent_app_country] => US
[patent_app_date] => 2003-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20182
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20060179497.pdf
[firstpage_image] =>[orig_patent_app_number] => 10537848
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/537848 | Methods to treat conditions associated with insulin signaling dysregulation | Dec 10, 2003 | Abandoned |
Array
(
[id] => 5619397
[patent_doc_number] => 20060188930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Isolated fluorescent protein from clytia gregaria cgfp and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/537614
[patent_app_country] => US
[patent_app_date] => 2003-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4995
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188930.pdf
[firstpage_image] =>[orig_patent_app_number] => 10537614
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/537614 | Isolated fluorescent protein from Clytia gregaria CGFP and use thereof | Nov 25, 2003 | Issued |
Array
(
[id] => 5648284
[patent_doc_number] => 20060134016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Drug to be introduced tooth or periodontal tissue and apparatus for introducing drug to tooth or periodontal tissue'
[patent_app_type] => utility
[patent_app_number] => 10/535696
[patent_app_country] => US
[patent_app_date] => 2003-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6730
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134016.pdf
[firstpage_image] =>[orig_patent_app_number] => 10535696
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/535696 | Drug to be introduced tooth or periodontal tissue and apparatus for introducing drug to tooth or periodontal tissue | Nov 20, 2003 | Abandoned |
Array
(
[id] => 5889775
[patent_doc_number] => 20060276383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Full length polynucleotide coding chicken type II collagen and the use of it'
[patent_app_type] => utility
[patent_app_number] => 10/534538
[patent_app_country] => US
[patent_app_date] => 2003-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12041
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20060276383.pdf
[firstpage_image] =>[orig_patent_app_number] => 10534538
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/534538 | Full length polynucleotide coding chicken type II collagen and the use of it | Nov 13, 2003 | Issued |
Array
(
[id] => 5619356
[patent_doc_number] => 20060188889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Use of differentially expressed nucleic acid sequences as biomarkers for cancer'
[patent_app_type] => utility
[patent_app_number] => 10/700439
[patent_app_country] => US
[patent_app_date] => 2003-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26772
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188889.pdf
[firstpage_image] =>[orig_patent_app_number] => 10700439
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/700439 | Use of differentially expressed nucleic acid sequences as biomarkers for cancer | Nov 3, 2003 | Abandoned |
Array
(
[id] => 7288072
[patent_doc_number] => 20040147469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Methods of inhibiting glial scar formation'
[patent_app_type] => new
[patent_app_number] => 10/698190
[patent_app_country] => US
[patent_app_date] => 2003-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 42590
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20040147469.pdf
[firstpage_image] =>[orig_patent_app_number] => 10698190
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/698190 | Methods of inhibiting glial scar formation | Oct 30, 2003 | Abandoned |
Array
(
[id] => 7374595
[patent_doc_number] => 20040219563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Method using gene trapped stem cells for making pathways of stem cell differentiation and making and isolating differentiated cells'
[patent_app_type] => new
[patent_app_number] => 10/685693
[patent_app_country] => US
[patent_app_date] => 2003-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 30346
[patent_no_of_claims] => 157
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20040219563.pdf
[firstpage_image] =>[orig_patent_app_number] => 10685693
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/685693 | Method using gene trapped stem cells for making pathways of stem cell differentiation and making and isolating differentiated cells | Oct 15, 2003 | Abandoned |
Array
(
[id] => 5865579
[patent_doc_number] => 20060099709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors'
[patent_app_type] => utility
[patent_app_number] => 10/529071
[patent_app_country] => US
[patent_app_date] => 2003-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18345
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099709.pdf
[firstpage_image] =>[orig_patent_app_number] => 10529071
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/529071 | Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors | Sep 30, 2003 | Abandoned |
Array
(
[id] => 7290885
[patent_doc_number] => 20040110714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Stabilized naked DNA compositions'
[patent_app_type] => new
[patent_app_number] => 10/675130
[patent_app_country] => US
[patent_app_date] => 2003-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4896
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110714.pdf
[firstpage_image] =>[orig_patent_app_number] => 10675130
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/675130 | Stabilized naked DNA compositions | Sep 29, 2003 | Abandoned |
Array
(
[id] => 5843373
[patent_doc_number] => 20060121557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Production of zeaxanthin by phaffia'
[patent_app_type] => utility
[patent_app_number] => 10/528848
[patent_app_country] => US
[patent_app_date] => 2003-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4950
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121557.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528848
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528848 | Production of zeaxanthin by phaffia | Sep 22, 2003 | Abandoned |
Array
(
[id] => 7463052
[patent_doc_number] => 20040053225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Enhancement of virus induced gene silencing (VIGS) through viral-based expression of inverted-repeats'
[patent_app_type] => new
[patent_app_number] => 10/660860
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7663
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053225.pdf
[firstpage_image] =>[orig_patent_app_number] => 10660860
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/660860 | Enhancement of virus induced gene silencing (VIGS) through viral-based expression of inverted-repeats | Sep 11, 2003 | Abandoned |
Array
(
[id] => 4639550
[patent_doc_number] => 08017577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-13
[patent_title] => 'Lyophilizable and enhanced compacted nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 10/656192
[patent_app_country] => US
[patent_app_date] => 2003-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 8420
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/017/08017577.pdf
[firstpage_image] =>[orig_patent_app_number] => 10656192
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/656192 | Lyophilizable and enhanced compacted nucleic acids | Sep 7, 2003 | Issued |
Array
(
[id] => 7237749
[patent_doc_number] => 20050080030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Methods and compositions for enhancing the delivery of a nucleic acid to a cell'
[patent_app_type] => utility
[patent_app_number] => 10/656068
[patent_app_country] => US
[patent_app_date] => 2003-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10557
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20050080030.pdf
[firstpage_image] =>[orig_patent_app_number] => 10656068
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/656068 | Methods and compositions for enhancing the delivery of a nucleic acid to a cell | Sep 4, 2003 | Abandoned |